(Q43917133)

28 November 2017

title

15-lipoxygenase-1 exerts its tumor suppressive role by inhibiting nuclear factor-kappa B via activation of PPAR gamma (English)

1 reference

28 November 2017

I Cimen

1

1 reference

28 November 2017

E Astarci

series ordinal

2

1 reference

28 November 2017

S Banerjee

series ordinal

3

1 reference

28 November 2017

publication date

1 September 2011

1 reference

Journal of Cellular Biochemistry

28 November 2017

published in

1 reference

28 November 2017

volume

112

1 reference

28 November 2017

issue

9

1 reference

28 November 2017

page(s)

2490-2501

1 reference

Nuclear factor-kappa B and cancer: its role in prevention and therapy

28 November 2017

cites work

1 reference

15-lipoxygenase-1 in colorectal cancer: a review.

21 January 2018

1 reference

Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity

21 January 2018

1 reference

Activation of PPAR gamma in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR gamma

21 January 2018

1 reference

The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene

21 January 2018

1 reference

Phosphorylation of PPARγ via active ERK1/2 leads to its physical association with p65 and inhibition of NF‐κβ

21 January 2018

1 reference

15-Lipoxygenase-1 expression suppresses the invasive properties of colorectal carcinoma cell lines HCT-116 and HT-29.

21 January 2018

1 reference

The role of cyclooxygenase and lipoxygenase in cancer chemoprevention

21 January 2018

1 reference

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells

21 January 2018

1 reference

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway

21 January 2018

1 reference

Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

Structural basis for the activation of PPARgamma by oxidized fatty acids

21 January 2018

1 reference

Platelet-type 12-lipoxygenase activates NF-kappaB in prostate cancer cells

21 January 2018

1 reference

NF-kappaB and cancer: mechanisms and targets

21 January 2018

1 reference

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

Human 15-lipoxygenase gene promoter: analysis and identification of DNA binding sites for IL-13-induced regulatory factors in monocytes

21 January 2018

1 reference

Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway

21 January 2018

1 reference

Eicosanoids in tumor progression and metastasis

21 January 2018

1 reference

Peroxisome-proliferator-activated receptors and cancers: complex stories

21 January 2018

1 reference

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

Evaluation of eicosanoids and NSAIDs as PPARgamma ligands in colorectal carcinoma cells

21 January 2018

1 reference

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

21 January 2018

1 reference

Can PPAR gamma ligands be used in cancer therapy?

21 January 2018

1 reference

Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties

21 January 2018

1 reference

Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.

21 January 2018

1 reference

The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis

21 January 2018

1 reference

Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis.

21 January 2018

1 reference

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

21 January 2018

1 reference

Nuclear factor-kappaB in development, prevention, and therapy of cancer

21 January 2018

1 reference

A gut feeling of the PXR, PPAR and NF-kappaB connection

21 January 2018

1 reference

Pioglitazone, a PPARgamma ligand, suppresses NFkappaB activation through inhibition of IkappaB kinase activation in cerulein-treated AR42J cells

21 January 2018

1 reference

NF-kappaB signaling pathway, inflammation and colorectal cancer.

21 January 2018

1 reference

Opposite action of peroxisome proliferator-activated receptor-gamma in regulating renal inflammation: functional switch by its ligand

21 January 2018

1 reference

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

21 January 2018

1 reference

Interleukin (IL)-4 indirectly suppresses IL-2 production by human T lymphocytes via peroxisome proliferator-activated receptor gamma activated by macrophage-derived 12/15-lipoxygenase ligands

21 January 2018

1 reference

15-LOX-1 inhibits p21 (Cip/WAF 1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cells

21 January 2018

1 reference

15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity

21 January 2018

1 reference

Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity

21 January 2018

1 reference

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.23174

1 reference

28 November 2017

1 reference